STOCK TITAN

Enovis Corp Financials

ENOV
FY2025 annual
Revenue $2.2B +6.7% YoY
Net Income -$1.2B -43.5% YoY
EPS (Diluted) -$20.75 -39.0% YoY
Free Cash Flow $19.9M +129.6% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 3, 2026 Reported Currency USD FYE December

Enovis Corp (ENOV) reported $2.2B in revenue for fiscal year 2025, up 6.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ENOV FY2025

Enovis’s dominant mechanic is a widening gap between operating cash generation and accounting profitability as asset charges reshape reported earnings.

In FY2025, EBITDA was $219.9M against depreciation and amortization of $1.34B, so the operating loss largely reflects noncash asset-related charges rather than the cash economics captured by EBITDA. Despite a net loss of -$1.18B, operating cash flow was $217M, showing that reported earnings and cash generation are describing materially different aspects of the business.

Gross economics improved: gross margin widened from 56.0% in FY2023 to 59.8% in FY2025 as revenue expanded, pointing to a margin shift beyond volume alone. That improvement did not reach free cash flow; FY2025 FCF was $19.9M after $197.4M of capital expenditures, leaving reinvestment to absorb nearly all operating cash.

Leverage is becoming more equity-sensitive: debt-to-equity increased from 0.5x in FY2024 to 0.8x in FY2025 while equity fell to $1.49B. The current ratio remained 2.0x, indicating more comfortable short-term coverage than the longer-term capital structure suggests.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 35 / 100
Financial Health Score 35/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Enovis Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
19

Enovis Corp has an operating margin of -50.0%, meaning the company loses $50 on every $100 of revenue. This results in a profitability score of 19/100. This is down from -36.8% the prior year.

Growth
75

Enovis Corp's revenue grew 6.7% year-over-year to $2.2B, a solid pace of expansion. This earns a growth score of 75/100.

Leverage
10

Enovis Corp has elevated debt relative to equity (D/E of 0.85), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 10/100, reflecting increased financial risk.

Liquidity
58

Enovis Corp's current ratio of 2.02 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
28

While Enovis Corp generated $217.3M in operating cash flow, capex of $197.4M consumed most of it, leaving $19.9M in free cash flow. This results in a low score of 28/100, reflecting heavy capital investment rather than weak cash generation.

Returns
19

Enovis Corp posts a -79.5% return on equity (ROE), meaning it loses $80 for every $100 of shareholders' equity. This results in a returns score of 19/100. This is down from -32.2% the prior year.

Altman Z-Score Distress
-0.36

Enovis Corp scores -0.36, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.4B) relative to total liabilities ($2.3B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Enovis Corp passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Enovis Corp reported a net loss of $1.2B while generating $217.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Enovis Corp reported an operating loss of $1.1B against $34.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.2B
YoY+6.7%
5Y CAGR+14.9%
10Y CAGR-4.1%

Enovis Corp generated $2.2B in revenue in fiscal year 2025. This represents an increase of 6.7% from the prior year.

EBITDA
$219.9M
YoY+44.6%
5Y CAGR+16.7%
10Y CAGR-5.9%

Enovis Corp's EBITDA was $219.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 44.6% from the prior year.

Net Income
-$1.2B
YoY-43.5%

Enovis Corp reported -$1.2B in net income in fiscal year 2025. This represents a decrease of 43.5% from the prior year.

EPS (Diluted)
-$20.75
YoY-39.0%

Enovis Corp earned -$20.75 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 39.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$19.9M
YoY+129.6%
5Y CAGR-36.1%
10Y CAGR-21.8%

Enovis Corp generated $19.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 129.6% from the prior year.

Cash & Debt
$36.4M
YoY-24.5%
5Y CAGR-17.8%
10Y CAGR-15.6%

Enovis Corp held $36.4M in cash against $1.3B in long-term debt as of fiscal year 2025.

Shares Outstanding
57M
YoY+0.5%

Enovis Corp had 57M shares outstanding in fiscal year 2025. This represents an increase of 0.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
59.8%
YoY+3.8pp
5Y CAGR+6.0pp
10Y CAGR+28.6pp

Enovis Corp's gross margin was 59.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3.8 percentage points from the prior year.

Operating Margin
-50.0%
YoY-13.2pp
5Y CAGR-44.1pp
10Y CAGR-57.7pp

Enovis Corp's operating margin was -50.0% in fiscal year 2025, reflecting core business profitability. This is down 13.2 percentage points from the prior year.

Net Margin
-52.7%
YoY-13.5pp
5Y CAGR-56.5pp
10Y CAGR-57.6pp

Enovis Corp's net profit margin was -52.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 13.5 percentage points from the prior year.

Return on Equity
-79.5%
YoY-47.3pp
5Y CAGR-80.7pp
10Y CAGR-85.0pp

Enovis Corp's ROE was -79.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 47.3 percentage points from the prior year.

Capital Allocation

R&D Spending
$120.3M
YoY+31.8%
5Y CAGR+28.6%

Enovis Corp invested $120.3M in research and development in fiscal year 2025. This represents an increase of 31.8% from the prior year.

Share Buybacks
$3.5M
YoY-26.6%

Enovis Corp spent $3.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 26.6% from the prior year.

Capital Expenditures
$197.4M
YoY+9.2%
5Y CAGR+11.5%
10Y CAGR+10.9%

Enovis Corp invested $197.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 9.2% from the prior year.

ENOV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ENOV quarterly income statement
MetricQ3'26Q2'26Q4'25Q3'25Q2'25Q4'24Q3'24Q2'24
Revenue$582.8M-1.1%$589.2M+7.3%$548.9M-2.8%$564.5M+1.0%$558.8M-0.4%$561.0M+11.0%$505.2M-3.8%$525.2M
Cost of Revenue$223.5M-0.1%$223.7M+1.7%$220.0M-4.3%$229.8M+1.4%$226.6M-10.6%$253.5M+15.9%$218.8M-7.4%$236.3M
Gross Profit$359.2M-1.7%$365.5M+11.1%$328.9M-1.7%$334.7M+0.7%$332.2M+8.0%$307.5M+7.4%$286.5M-0.8%$288.9M
R&D Expenses$31.7M+0.5%$31.5M+6.0%$29.7M-3.1%$30.7M+7.6%$28.5M+19.1%$24.0M+16.9%$20.5M-12.7%$23.5M
SG&A Expenses$263.7M-6.7%$282.8M+7.3%$263.6M-1.3%$267.1M-0.7%$269.0M+4.4%$257.7M+3.1%$249.9M-5.4%$264.1M
Operating Income$17.4M+166.7%$6.5M+101.2%-$558.5M-3225.1%-$16.8M+64.1%-$46.8M+93.0%-$664.7M-1994.6%-$31.7M+28.2%-$44.2M
Interest Expense$8.0M-12.3%$9.2M+3.9%$8.8M-5.0%$9.3M+1.2%$9.2M+1.3%$9.1M-18.0%$11.1M-34.8%$17.0M
Income Tax$8.5M-6.0%$9.0M+125.8%$4.0M-62.9%$10.8M+710.6%-$1.8M-105.9%$29.9M+428.7%-$9.1M-2.1%-$8.9M
Net Income-$1.2M+86.4%-$8.8M+98.5%-$571.1M-1454.6%-$36.7M+34.4%-$56.0M+92.0%-$703.3M-2131.3%-$31.5M-69.1%-$18.6M
EPS (Diluted)-$0.02+86.7%-$0.15+98.5%-$9.99-1460.9%-$0.64+34.7%-$0.98+92.3%-$12.70-2089.7%-$0.58-70.6%-$0.34

ENOV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ENOV quarterly balance sheet
MetricQ3'26Q2'26Q4'25Q3'25Q2'25Q4'24Q3'24Q2'24
Total Assets$3.8B-1.7%$3.8B-13.6%$4.4B-11.7%$5.0B+3.0%$4.9B+3.3%$4.7B-15.0%$5.6B+2.0%$5.4B
Current Assets$1.2B-2.0%$1.2B-3.2%$1.3B0.0%$1.3B+5.1%$1.2B+6.3%$1.1B-4.7%$1.2B+2.6%$1.2B
Cash & Equivalents$12.6M-62.1%$33.1M-1.5%$33.6M-23.7%$44.1M+14.6%$38.5M-20.2%$48.2M+36.0%$35.4M+1.2%$35.0M
Inventory$601.7M-0.1%$602.5M-1.8%$613.8M-2.3%$628.2M+7.2%$585.9M+7.1%$547.1M-10.3%$609.7M-0.9%$615.0M
Accounts Receivable$441.8M-0.5%$444.2M+2.9%$431.8M-4.8%$453.7M+4.2%$435.6M+7.0%$407.0M+1.7%$400.2M+1.4%$394.7M
Goodwill$709.9M-0.3%$711.9M-41.6%$1.2B-31.6%$1.8B+2.8%$1.7B+2.4%$1.7B-29.3%$2.4B+1.7%$2.4B
Total Liabilities$2.3B-2.8%$2.4B-2.4%$2.4B-1.3%$2.4B+8.2%$2.3B+4.7%$2.2B-2.8%$2.2B+3.0%$2.2B
Current Liabilities$612.1M+0.6%$608.7M+5.8%$575.4M+1.3%$568.2M+19.0%$477.4M-9.7%$529.0M-0.2%$530.2M+2.4%$518.0M
Long-Term Debt$1.2B-3.4%$1.3B-3.6%$1.3B-2.5%$1.4B+0.4%$1.4B+4.4%$1.3B-1.2%$1.3B-0.3%$1.3B
Total Equity$1.5B0.0%$1.5B-26.9%$2.0B-21.6%$2.6B-1.5%$2.6B+2.2%$2.6B-23.1%$3.3B+1.3%$3.3B
Retained Earnings-$1.5B-0.1%-$1.5B-55.9%-$946.9M-152.0%-$375.7M-10.8%-$339.0M-19.8%-$283.0M-167.3%$420.3M-7.0%$451.8M

ENOV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ENOV quarterly cash flow statement
MetricQ3'26Q2'26Q4'25Q3'25Q2'25Q4'24Q3'24Q2'24
Operating Cash Flow$75.0M+213.3%$24.0M-71.0%$82.6M+72.9%$47.8M+3093.0%-$1.6M-101.8%$88.3M+64.9%$53.6M+589.0%$7.8M
Capital Expenditures$43.9M-16.9%$52.8M-1.3%$53.5M+20.6%$44.4M+2.6%$43.3M-18.7%$53.2M+3.9%$51.2M+29.9%$39.4M
Free Cash Flow$31.1M+207.9%-$28.9M-199.2%$29.1M+755.4%$3.4M+107.6%-$44.9M-227.7%$35.1M+1383.9%$2.4M+107.5%-$31.6M
Investing Cash Flow-$45.0M+15.2%-$53.1M+5.3%-$56.1M-12.6%-$49.8M+17.7%-$60.5M-4.6%-$57.9M+0.9%-$58.4M-41.4%-$41.3M
Financing Cash Flow-$50.6M-294.3%$26.0M+170.5%-$36.9M-692.3%$6.2M-87.8%$51.2M+354.9%-$20.1M-13467.6%-$148K-105.9%$2.5M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ENOV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ENOV quarterly financial ratios
MetricQ3'26Q2'26Q4'25Q3'25Q2'25Q4'24Q3'24Q2'24
Gross Margin61.6%-0.4pp62.0%+2.1pp59.9%+0.6pp59.3%-0.2pp59.5%+4.6pp54.8%-1.9pp56.7%+1.7pp55.0%
Operating Margin3.0%+1.9pp1.1%-101.7%-3.0%+5.4pp-8.4%-118.5%-6.3%+2.1pp-8.4%
Net Margin-0.2%+1.3pp-1.5%-104.0%-6.5%+3.5pp-10.0%-125.4%-6.2%-2.7pp-3.5%
Return on Equity-0.1%+0.5pp-0.6%+27.7pp-28.3%-26.9pp-1.4%+0.7pp-2.1%+25.3pp-27.4%-26.5pp-0.9%-0.4pp-0.6%
Return on Assets0.0%+0.2pp-0.2%+12.7pp-12.9%-12.2pp-0.7%+0.4pp-1.1%+13.8pp-14.9%-14.3pp-0.6%-0.2pp-0.3%
Current Ratio1.98-0.1x2.04-0.2x2.220.0x2.25-0.3x2.55+0.4x2.17-0.1x2.270.0x2.26
Debt-to-Equity0.840.0x0.87+0.2x0.66+0.1x0.530.0x0.520.0x0.51+0.1x0.400.0x0.40
FCF Margin5.3%+10.2pp-4.9%-10.2pp5.3%+4.7pp0.6%+8.6pp-8.0%-14.3pp6.3%+5.8pp0.5%+6.5pp-6.0%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Frequently Asked Questions

What is Enovis Corp's annual revenue?

Enovis Corp (ENOV) reported $2.2B in total revenue for fiscal year 2025. This represents a 6.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Enovis Corp's revenue growing?

Enovis Corp (ENOV) revenue grew by 6.7% year-over-year, from $2.1B to $2.2B in fiscal year 2025.

Is Enovis Corp profitable?

No, Enovis Corp (ENOV) reported a net income of -$1.2B in fiscal year 2025, with a net profit margin of -52.7%.

Enovis Corp (ENOV) reported diluted earnings per share of -$20.75 for fiscal year 2025. This represents a -39.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Enovis Corp (ENOV) had EBITDA of $219.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Enovis Corp (ENOV) had $36.4M in cash and equivalents against $1.3B in long-term debt.

Enovis Corp (ENOV) had a gross margin of 59.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Enovis Corp (ENOV) had an operating margin of -50.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Enovis Corp (ENOV) had a net profit margin of -52.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Enovis Corp (ENOV) has a return on equity of -79.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Enovis Corp (ENOV) generated $19.9M in free cash flow during fiscal year 2025. This represents a 129.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Enovis Corp (ENOV) generated $217.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Enovis Corp (ENOV) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Enovis Corp (ENOV) invested $197.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Enovis Corp (ENOV) invested $120.3M in research and development during fiscal year 2025.

Yes, Enovis Corp (ENOV) spent $3.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Enovis Corp (ENOV) had 57M shares outstanding as of fiscal year 2025.

Enovis Corp (ENOV) had a current ratio of 2.02 as of fiscal year 2025, which is generally considered healthy.

Enovis Corp (ENOV) had a debt-to-equity ratio of 0.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Enovis Corp (ENOV) had a return on assets of -30.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Enovis Corp (ENOV) has an Altman Z-Score of -0.36, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Enovis Corp (ENOV) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Enovis Corp (ENOV) reported a net loss of $1.2B while generating $217.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Enovis Corp (ENOV) reported an operating loss of $1.1B against $34.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Enovis Corp (ENOV) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top